Sloan Kettering Gets Trimmed Fees In IP Fight
By Adam Rhodes · January 2, 2018, 8:19 PM EST
A New York federal judge ordered Errant Gene Therapeutics LLC to pay the Sloan Kettering Institute for Cancer Research $88,339 in attorneys' fees Tuesday after the biopharmaceutical company was sanctioned for...
To view the full article, register now.